117 related articles for article (PubMed ID: 19713755)
21. PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFκB.
Xu J; Ren X; Pathania AS; Fernandez GE; Tran A; Zhang Y; Moats RA; Shackleford GM; Erdreich-Epstein A
Sci Rep; 2017 Apr; 7(1):835. PubMed ID: 28400607
[TBL] [Abstract][Full Text] [Related]
22. Toward the Synthesis of Nuphar Sesquiterpene Thioalkaloids: Stereodivergent Rhodium-Catalyzed Synthesis of the Thiolane Subunit.
Lu P; Herrmann AT; Zakarian A
J Org Chem; 2015 Aug; 80(15):7581-9. PubMed ID: 26147579
[TBL] [Abstract][Full Text] [Related]
23. Potent immunosuppressive principles, dimeric sesquiterpene thioalkaloids, isolated from nupharis rhizoma, the rhizoma of Nuphar pumilum (nymphaeaceae): structure-requirement of nuphar-alkaloid for immunosuppressive activity.
Yamahara J; Shimoda H; Matsuda H; Yoshikawa M
Biol Pharm Bull; 1996 Sep; 19(9):1241-3. PubMed ID: 8889051
[TBL] [Abstract][Full Text] [Related]
24. 1'S-1'-acetoxyeugenol acetate: a novel phenylpropanoid from Alpinia conchigera enhances the apoptotic effects of paclitaxel in MCF-7 cells through NF-κB inactivation.
In LL; Azmi MN; Ibrahim H; Awang K; Nagoor NH
Anticancer Drugs; 2011 Jun; 22(5):424-34. PubMed ID: 21346553
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts.
Mohammad RM; Banerjee S; Li Y; Aboukameel A; Kucuk O; Sarkar FH
Cancer; 2006 Mar; 106(6):1260-8. PubMed ID: 16475211
[TBL] [Abstract][Full Text] [Related]
26. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
Lee TK; Poon RT; Wo JY; Ma S; Guan XY; Myers JN; Altevogt P; Yuen AP
Cancer Res; 2007 Sep; 67(18):8800-9. PubMed ID: 17875721
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of nuclear factor κB by MIP-based drug combinations augments cell death of breast cancer cells.
Subramaniam M; Liew SK; In L; Awang K; Ahmed N; Nagoor NH
Drug Des Devel Ther; 2018; 12():1053-1063. PubMed ID: 29750018
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.
Rahman KM; Ali S; Aboukameel A; Sarkar SH; Wang Z; Philip PA; Sakr WA; Raz A
Mol Cancer Ther; 2007 Oct; 6(10):2757-65. PubMed ID: 17913854
[TBL] [Abstract][Full Text] [Related]
29. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N
J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634
[TBL] [Abstract][Full Text] [Related]
30. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells.
Gaikwad SM; Thakur B; Sakpal A; Singh RK; Ray P
Int J Biochem Cell Biol; 2015 Apr; 61():90-102. PubMed ID: 25681684
[TBL] [Abstract][Full Text] [Related]
31. Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells.
Czarnomysy R; Surażyński A; Popławska B; Rysiak E; Pawłowska N; Czajkowska A; Bielawski K; Bielawska A
Mol Cell Biochem; 2017 Mar; 427(1-2):13-22. PubMed ID: 27995416
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor kappaB by black raspberry extracts.
Huang C; Huang Y; Li J; Hu W; Aziz R; Tang MS; Sun N; Cassady J; Stoner GD
Cancer Res; 2002 Dec; 62(23):6857-63. PubMed ID: 12460899
[TBL] [Abstract][Full Text] [Related]
33. NF-κB inhibitory activities of glycosides and alkaloids from Zanthoxylum schinifolium stems.
Li W; Yang SY; Yan XT; Sun YN; Song SB; Kang HK; Kim YH
Chem Pharm Bull (Tokyo); 2014; 62(2):196-202. PubMed ID: 24492590
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel.
Kim SM; Lee SY; Yuk DY; Moon DC; Choi SS; Kim Y; Han SB; Oh KW; Hong JT
Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891
[TBL] [Abstract][Full Text] [Related]
35. Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-kappaB.
Lee SY; Cho JS; Yuk DY; Moon DC; Jung JK; Yoo HS; Lee YM; Han SB; Oh KW; Hong JT
J Pharmacol Sci; 2009 Oct; 111(2):124-36. PubMed ID: 19834284
[TBL] [Abstract][Full Text] [Related]
36. Pao Pereira Extract Suppresses Castration-Resistant Prostate Cancer Cell Growth, Survival, and Invasion Through Inhibition of NFκB Signaling.
Chang C; Zhao W; Xie B; Deng Y; Han T; Cui Y; Dai Y; Zhang Z; Gao J; Guo H; Yan J
Integr Cancer Ther; 2014 May; 13(3):249-58. PubMed ID: 24287876
[TBL] [Abstract][Full Text] [Related]
37. Triptolide sensitizes human breast cancer cells to tumor necrosis factor‑α‑induced apoptosis by inhibiting activation of the nuclear factor‑κB pathway.
Cheng X; Shi W; Zhao C; Zhang D; Liang P; Wang G; Lu L
Mol Med Rep; 2016 Apr; 13(4):3257-64. PubMed ID: 26935527
[TBL] [Abstract][Full Text] [Related]
38. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
Shukla S; Gupta S
Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
[TBL] [Abstract][Full Text] [Related]
39. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
[TBL] [Abstract][Full Text] [Related]
40. Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-kappaB independent pathway.
Takizawa K; Kamijo R; Ito D; Hatori M; Sumitani K; Nagumo M
Br J Cancer; 1999 Jun; 80(7):954-63. PubMed ID: 10362102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
